April 23, 2024
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
February 29, 2024
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
February 21, 2024
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
February 6, 2024
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
February 1, 2024